Regency Centers director receives stock awards

Regency Centers Corp director Karin Klein reported equity-based compensation on May 6, 2026.

Rhea-AI Filing Summary

Regency Centers Corp director Karin Klein reported equity-based compensation on May 6, 2026. She received 403 shares of Common Stock as director’s fees paid in stock under Regency’s Omnibus Incentive Plan, bringing her directly held Common Stock to 23,601 shares.

She also acquired a Restricted Stock Grant covering 2,150 shares of Common Stock through a derivative transaction. According to the disclosure, these restricted shares vest 100% on May 6, 2027, reflecting a time-based compensation award rather than an open-market trade.

Insider Trade Summary

2,150 shares exercised/converted

Exercise 2 txns

Insider Klein Karin

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Grant	2,150	$0.00	$0.00
Grant/Award	Common Stock	403	$0.00	$0.00

Holdings After Transaction: Restricted Stock Grant — 2,150 contracts (Direct); Common Stock — 23,601 shares (Direct)

Footnotes (2)

1. F1. Represents director's fees paid in stock pursuant to Regency's Omnibus Incentive Plan.
2. F2. Shares vest 100% on May 6, 2027.

Key Figures

Director fee shares: 403 shares Common shares after award: 23,601 shares Restricted Stock Grant size: 2,150 shares +3 more

6 metrics

Director fee shares 403 shares Common Stock paid as director’s fees in stock

Common shares after award 23,601 shares Directly held Common Stock after May 6, 2026 award

Restricted Stock Grant size 2,150 shares Underlying Common Stock tied to Restricted Stock Grant

Restricted stock vesting date May 6, 2027 Restricted Stock Grant vests 100% on this date

Exercise/conversion price $0.00 per share Conversion or exercise price for Restricted Stock Grant

Acquisition transactions 2 transactions Both reported as acquisitions, none as sales

Key Terms

Omnibus Incentive Plan, Restricted Stock Grant, director's fees, vest

4 terms

Omnibus Incentive Plan financial

"Represents director's fees paid in stock pursuant to Regency's Omnibus Incentive Plan."

An omnibus incentive plan is a single, flexible program a company uses to give employees and executives different types of pay tied to performance — for example stock options, restricted shares, cash bonuses and other awards — all governed by one set of rules. It matters to investors because it determines how many new shares may be created, how leaders are motivated and how much the company will spend on compensation over time; think of it as a master toolbox that affects both costs and the total share supply.

Restricted Stock Grant financial

"security_title: "Restricted Stock Grant" with underlying Common Stock shares."

A restricted stock grant is an award of company shares given to an employee or executive that cannot be sold or transferred until certain conditions are met, such as staying with the company for a set time or hitting performance goals. For investors, it signals how the company ties pay to future performance and can affect the number of shares outstanding and management’s incentives—think of it as a wrapped gift you only keep once you meet the requirements.

director's fees financial

"Represents director's fees paid in stock pursuant to Regency's Omnibus Incentive Plan."

vest financial

"Shares vest 100% on May 6, 2027."

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Karin Klein report for REG on May 6, 2026?

Director Karin Klein reported equity awards rather than open-market trades. She received 403 Common Stock shares as director’s fees and a Restricted Stock Grant for 2,150 underlying shares, both dated May 6, 2026, as part of Regency Centers’ compensation programs.

How many Regency Centers (REG) shares does Karin Klein hold after this Form 4?

After the May 6, 2026 transactions, Karin Klein directly holds 23,601 shares of Regency Centers Common Stock. This total reflects her position following receipt of 403 shares paid as director’s fees under the company’s Omnibus Incentive Plan.

What is the nature of the 403 REG shares reported by Karin Klein?

The 403 shares are director’s fees paid in stock under Regency’s Omnibus Incentive Plan. Instead of cash, the company compensated her with Common Stock, which is a routine form of non-cash board compensation and not an open-market share purchase or sale.

What are the terms of Karin Klein’s Restricted Stock Grant in REG?

Karin Klein reported a Restricted Stock Grant linked to 2,150 underlying Common Stock shares. The shares vest 100% on May 6, 2027, meaning the award becomes fully hers on that date if conditions are satisfied, aligning with time-based equity compensation practices.

Did Karin Klein buy or sell Regency Centers (REG) shares on the market?

The Form 4 shows no open-market buys or sells. All reported activity is classified as acquisitions: stock paid as director’s fees and a Restricted Stock Grant. There are no sale transactions or tax-withholding dispositions disclosed in this particular filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/08/2026 - 12:19 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Klein Karin

(Last) (First) (Middle)

C/O REGENCY CENTERS CORPORATION

ONE INDEPENDENT DRIVE SUITE 114

(Street)

JACKSONVILLE FLORIDA 32202

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
REGENCY CENTERS CORP [ REG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/06/2026		A		403	A	(1)	23,601	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Grant	$0	05/06/2026		M		2,150		(2)	(2)	Common Stock	2,150	$0	2,150	D

Explanation of Responses:

1. Represents director's fees paid in stock pursuant to Regency's Omnibus Incentive Plan.

2. Shares vest 100% on May 6, 2027.

Remarks:

	/s/Michael R. Herman Attorney-in-Fact	05/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)